CSF1R and diabetes mellitus: To investigate whether CSF1R-stimulated microglia prevent diabetes-induced neuropathy similar to OAL-microglia in vivo, STZ was applied to neurons treated with CSF1R-stimulated microglia culture supernatant (CSF1R-stimulated MCS).